FTC Demands More Info On $1.6B Charles River Deal
The Federal Trade Commission is seeking additional information on Charles River Laboratories International Inc.'s plan to buy China's WuXi PharmaTech (Cayman) Inc. in a $1.6 billion cash-and-stock merger....To view the full article, register now.
Already a subscriber? Click here to view full article